Log in
LON:ZTF

Zotefoams Share Forecast, Price & News

GBX 440
+5.00 (+1.15 %)
(As of 10/23/2020 03:10 PM ET)
Add
Compare
Today's Range
420.80
Now: GBX 440
440
50-Day Range
410
MA: GBX 443.69
500
52-Week Range
4.22
Now: GBX 440
530
Volume143,514 shs
Average Volume63,387 shs
Market Capitalization£213.93 million
P/E Ratio34.38
Dividend Yield0.93%
BetaN/A
Zotefoams plc, together with its subsidiaries, manufactures, distributes, and sells polymer foam in the United Kingdom and Eire, Continental Europe, North America, and internationally. The company operates through Polyolefins, High-Performance Products (HPP), and MuCell Extrusion LLC (MEL) segments. It offers AZOTE family of polyolefin foams under the Plastazote, Evazote, and Supazote brands; and ZOTEK range of high-performance foams manufactured from fluoropolymers, engineering polymers, and specialty elastomers under the ZOTEK F, ZOTEK N, and ZOTEK PEBA brand names. The company also provides T-FIT, an advanced insulation system designed for use in clean process manufacture in the biotechnology, pharmaceuticals, and semiconductor industries. In addition, it owns and licenses patented MuCell microcellular foams technology that is used in consumer packaging; and sells related machinery. The company serves automotive, aerospace, packaging, industrial parts, marine, building and construction, military, and sports and leisure industries. Zotefoams plc was incorporated in 1992 and is based in Croydon, the United Kingdom.
Read More
Zotefoams logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.6Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.11 out of 5 stars

Industry, Sector and Symbol

Industry Specialty Chemicals
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+44-20-86641600
Employees459

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£73.19 million
Cash FlowGBX 25.30 per share
Book ValueGBX 190.80 per share

Profitability

Miscellaneous

Market Cap£213.93 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 440
+5.00 (+1.15 %)
(As of 10/23/2020 03:10 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ZTF News and Ratings via Email

Sign-up to receive the latest news and ratings for ZTF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Zotefoams (LON:ZTF) Frequently Asked Questions

How has Zotefoams' stock price been impacted by COVID-19 (Coronavirus)?

Zotefoams' stock was trading at GBX 316 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ZTF shares have increased by 39.2% and is now trading at GBX 440.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Zotefoams?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zotefoams in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Zotefoams
.

How were Zotefoams' earnings last quarter?

Zotefoams plc (LON:ZTF) released its quarterly earnings data on Tuesday, August, 11th. The company reported $4.48 earnings per share (EPS) for the quarter.
View Zotefoams' earnings history
.

How often does Zotefoams pay dividends? What is the dividend yield for Zotefoams?

Zotefoams declared a dividend on Tuesday, August 11th. Shareholders of record on Thursday, September 10th will be given a dividend of GBX 2.03 per share on Friday, October 9th. This represents a yield of 0.47%. The ex-dividend date is Thursday, September 10th. The official announcement can be seen at this link.
View Zotefoams' dividend history
.

What price target have analysts set for ZTF?

1 equities research analysts have issued 1-year price targets for Zotefoams' stock. Their forecasts range from GBX 350 to GBX 350. On average, they expect Zotefoams' stock price to reach GBX 350 in the next year. This suggests that the stock has a possible downside of 20.5%.
View analysts' price targets for Zotefoams
.

Who are some of Zotefoams' key competitors?

What other stocks do shareholders of Zotefoams own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Zotefoams investors own include Applied Graphene Materials plc (AGM.L) (AGM), NetApp (NTAP), Twitter (TWTR), First Derivatives plc (FDP.L) (FDP), TiVo (TIVO), Vodafone Group (VOD), EMC (EMC), Eros STX Global (EROS), Frontier Developments (FDEV) and FDM Group (FDM).

Who are Zotefoams' key executives?

Zotefoams' management team includes the following people:
  • Mr. David B. Stirling BSC CA, MBA, MSC, Group CEO, MD & Director (Age 52)
  • Mr. Gary C. McGrath, Group CFO & Director
  • James W. Kindell, Company Sec.
  • Sara Hollowell, Interim Company Sec.

What is Zotefoams' stock symbol?

Zotefoams trades on the London Stock Exchange (LON) under the ticker symbol "ZTF."

How do I buy shares of Zotefoams?

Shares of ZTF and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Zotefoams' stock price today?

One share of ZTF stock can currently be purchased for approximately GBX 440.

How big of a company is Zotefoams?

Zotefoams has a market capitalization of £213.93 million and generates £73.19 million in revenue each year. Zotefoams employs 459 workers across the globe.

What is Zotefoams' official website?

The official website for Zotefoams is www.zotefoams.com.

How can I contact Zotefoams?

Zotefoams' mailing address is 675 Mitcham Road, CROYDON, CR9 3AL, United Kingdom. The company can be reached via phone at +44-20-86641600.

This page was last updated on 10/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.